Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses against HCMV Proteins IE1 and IE2

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

(2013) A. M. Leen et al.   BLOOD

Human cytomegalovirus immediate early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis

(2013) Zahidul Khan et al.   CARCINOGENESIS

The “Silent” Global Burden of Congenital Cytomegalovirus

(2013) Sheetal Manicklal et al.   CLINICAL MICROBIOLOGY REVIEWS

A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population

(2013) Denise M. McKinney et al.   IMMUNOGENETICS

Survival in Patients with Glioblastoma Receiving Valganciclovir

(2013) Cecilia Söderberg-Nauclér et al.   NEW ENGLAND JOURNAL OF MEDICINE

MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

(2013) Peter Braendstrup et al.   PLoS One

Presentation of an Immunodominant Immediate-Early CD8+ T Cell Epitope Resists Human Cytomegalovirus Immunoevasion

(2013) Stefanie Ameres et al.   PLoS Pathogens

Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity

(2012) Mikkel Harndahl et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection

(2012) Rob S Sellar et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

MHC Class II Tetramers

(2012) G. T. Nepom   JOURNAL OF IMMUNOLOGY

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

(2012) Paul D Griffiths   LANCET INFECTIOUS DISEASES

Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection

(2012) Stefan Ebert et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh-density Peptide Microarrays

(2012) Søren Buus et al.   MOLECULAR & CELLULAR PROTEOMICS

Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials

(2012) Cliona Rooney et al.   Molecular Therapy-Nucleic Acids

Adoptive immunotherapy with virus-specific T cells

(2011) Shigeo Fuji et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools

(2011) L. Zhang et al.   BRIEFINGS IN BIOINFORMATICS

Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

(2011) Claus Lundegaard et al.   Expert Review of Vaccines

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells

(2010) Antje Hoff et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

HLArestrictor—a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides

(2010) Malene Erup Larsen et al.   IMMUNOGENETICS

Immunotherapy and Vaccination After Transplant: The Present, the Future

(2010) Vincent C. Emery et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Real-time, high-throughput measurements of peptide–MHC-I dissociation using a scintillation proximity assay

(2010) Mikkel Harndahl et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Peptide-MHC Cellular Microarray with Innovative Data Analysis System for Simultaneously Detecting Multiple CD4 T-Cell Responses

(2010) Xinhui Ge et al.   PLoS One

Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection

(2010) Michael J. Cannon et al.   REVIEWS IN MEDICAL VIROLOGY

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

(2010) Anita Schmitt et al.   TRANSFUSION

Is HCMV a tumor promoter?

(2010) Liliana Soroceanu et al.   VIRUS RESEARCH

Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning

(2009) Alexander H. Schmidt et al.   HUMAN IMMUNOLOGY

Tricks with tetramers: how to get the most from multimeric peptide-MHC

(2009) Linda Wooldridge et al.   IMMUNOLOGY

Class II major histocompatibility complex tetramer staining: progress, problems, and prospects

(2008) Sabrina S. Vollers et al.   IMMUNOLOGY

A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models

(2008) A KRISHNAN et al.   IMMUNOLOGY LETTERS

Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring

(2008) Alexander Kirchner et al.   JOURNAL OF MEDICAL VIROLOGY

One-Pot, Mix-and-Read Peptide-MHC Tetramers

(2008) Christian Leisner et al.   PLoS One